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Ovarian stimulation as used in women in connection with in-vitro fertilization (IVF) aims at overriding the normal growth by increasing the circulating concentrations of follicle stimulating hormone (FSH) . According to the now 3 To whom correspondence should be addressed at: Fertility Clinic, proven two-cell, two-gonadotrophin concept, it is evident that Odense University Hospital, DK-5000 Odense C., Denmark both FSH and luteinizing hormone (LH) are required for normal The impact of suppressed concentrations of circulating follicular oestradiol biosynthesis. However, it is commonly luteinizing hormone (LH) during ovarian stimulation on believed that low (so-called resting) concentrations of circuthe outcome of in-vitro fertilization or intracytoplasmic lating LH are sufficient to support development and maturation sperm injection treatment in 200 consecutive, normoof follicles and oocytes in normogonadotrophic women gonadotrophic women (couples) was analysed retrospec- (Chappel and Howles, 1991) . During recent years it has been tively. A standard stimulation protocol with mid-luteal common practice to combine gonadotrophin-releasing hormone gonadotrophin-releasing hormone (GnRH) agonist down-(GnRH) analogue-induced pituitary suppression with highly regulation and ovarian stimulation with recombinant purified urinary or recombinant FSH for ovarian stimulation follicle stimulating hormone (FSH) was used in all cases.
in IVF. This combination results in concentrations of circulating Blood was sampled from each woman on stimulation days LH that are much lower than during the follicular phase of 1 and 8 for analysis of oestradiol and LH in serum. A the normal menstrual cycle. The reasons for this are that the pure FSH preparations-in contrast to the classical urinary threshold value of serum LH of 0.5 IU/l on stimulation day human menopausal gonadotrophins (HMG)-are devoid of 8 (S8) was chosen to discriminate between women with LH activity, and that the GnRH analogue more or less prohibits low or 'normal' LH concentrations. Low concentrations pituitary release of endogenous LH. These low concentrations of LH on S8 (<0.5 IU/l) were found in 49% (98/200) of of LH lead to a reduced thecal production of androgen the women. This group of women was comparable with precursors, and consequently to a reduction of ovarian oestrathe normal LH group with regard to pre-treatment clinical diol biosynthesis, as shown in a number of clinical studies parameters, and to the parameters characterizing the (Fleming et al., 1996; Westergaard et al., 1996 ; Agrawal stimulation protocol with the exception of serum oestradiol et al., 1998) . concentration, which on S8 was significantly lower than in Studies in GnRH antagonist down-regulated primates the normal LH group (P < 0.001). The proportion of indicate that an intrafollicular environment depleted of LH positive pregnancy tests was similar in the two groups and oestradiol negatively affects oocyte maturation, embryo (30% versus 34% per started cycle), but the final clinical development and ability to implant (Weston et al., 1996) . treatment outcome was significantly different, with a fiveClinical studies in women with hypogonadal hypogonadism fold higher risk of early pregnancy loss (45% versus 9%; have shown that while follicular development can be achieved P < 0.005) in the low LH group and consequently a by stimulation with pure FSH preparations, concentrations of significantly poorer chance of delivery than in the normal circulating oestradiol and fertilization rates of retrieved oocytes LH group. It is concluded that a substantial proportion of are severely compromised compared to stimulation with prenormogonadotrophic women treated with GnRH agonist parations containing LH activity (Shoham et al., 1991 ; Balasch down-regulation in combination with FSH, devoid of LH et al., 1995) . Similarly, in normogonadotrophic women treated activity, experience LH suppression, which compromises with GnRH analogues and highly purified FSH, a lower yield the treatment outcome. Whether these women would of oocytes, lower fertilization rates and reduced embryo quality benefit from supplementation with recombinant LH or was found in the group of women (one-third of all) with low human menopausal gonadotrophin during ovarian LH (Ͻ0.5 IU/l) and low oestradiol concentrations in the midstimulation, remains to be proven in the future by follicular phase as compared with the group of women with prospective randomized trials. The aim of the present retrospective study was to examine
The detection limit of this assay was 0.5 IU/l, defined as the the impact of circulating LH concentrations in the midconcentration at two SD from the AxSYM LH calibrator A (0 IU/l) follicular phase of ovarian stimulation on the outcome of (Abbott Laboratories, 100 Abbott Park Road, IL, USA). Using a IVF in normogonadotrophic women subjected to pituitary serum with a mean LH concentration of 0.66 IU/l, intra-and intersuppression with GnRH analogue from the mid-luteal phase, assay CV of this assay were found to be 8.5% and 11.6% respectively followed by ovarian stimulation with recombinant FSH.
(n ϭ 5).
The correlation coefficient between the two LH assays used was 0.92 (P Ͻ 0.0001), when analysing all samples. Analysing samples with LH concentration below 0.5 IU/l showed a correlation coefficient Fleming et al., 1998) , a serum LH concentration of 0.5 during the period August 1997 to August 1998 consecutively fulfilled IU/l on stimulation day 8 was chosen, as assayed by the AutoDELthe below-mentioned inclusion criteria. These were: (i) female age PHIA assay, as the threshold value to discriminate between the group below 40 years; (ii) regular menstrual cycles with pre-treatment of patients with low LH concentrations from those with 'normal' concentrations of FSH and LH on cycle day 2 below 10 IU/l; (iii) LH concentrations and compare treatment outcome between the standard hormonal treatment as follows: pituitary down-regulation two groups. with GnRH agonist (GnRHa) (Suprefact; Hoechst, 2970 Horsholm, Denmark) 0.5 mg s.c. daily for 14 days from the mid-luteal phase.
Statistical methods After down-regulation was ascertained with ultrasound and serum
Differences between the two groups of patients were tested statistically oestradiol (Ͻ200 pmol), the dose of GnRHa was reduced to 0.2 mg by use of the χ 2 test and the Wilcoxon rank sum test. s.c. daily and ovarian stimulation was started with recombinant FSH (Gonal-F; Serono Nordic, 2100 Copenhagen, Denmark) in a fixed dose of 225 IU s.c. per day for 7 days (stimulation days 1 to 7).
Results
The ovarian response was monitored by ultrasound and serum On stimulation day 8 (S8), serum concentrations of LH were oestradiol again on stimulation day 8, and the dose of FSH adjusted Ͻ0.5 IU/l in 98 cycles (women) and Ͼ0.5 IU/l in the if necessary. When at least four follicles had reached a diameter remaining 102 cycles (women), with a median concentration of Ͼ16 mm, an ovulatory dose of human chorionic gonadotrophin 0.52 IU/l for the whole patient cohort.
(HCG) (Profasi; Serono) 10 000 IU s.c. was given and oocyte retrieval performed 36 h later by vaginal ultrasound-guided follicle
The demographic characteristics of all the women/couples aspiration. Details on oocyte insemination, in-vitro culture and and grouped according to S8 LH concentrations above or pre-embryo transfer have been described previously (Westergaard below 0.5 IU/l are shown in Table I . Female age, number of et al., 1996) . A maximum of two pre-embryos was transferred previous IVF attempts, body mass index and pre-treatment after 3 days in culture, and surplus, transferable pre-embryos were concentrations of FSH and LH were similar between the low cryopreserved. The luteal phase was supported by daily vaginal and normal LH groups. The most common infertility diagnosis, administration of 300 mg micronized progesterone (Progestan; tubal and male infertility were also similar, but significantly Organon A/S, Skovlunde, Denmark) beginning 2 days before premore couples in the low LH group were diagnosed with embryo transfer and continuing until the day of pregnancy test. In idiopathic infertility. The similarity between the two groups cases of a positive test this regime was continued for another 3 with regard to cancellation rate, duration of ovarian stimulation, weeks. In no case were HCG injections used for luteal phase support.
consumption of gonadotrophins, mean number of retrieved, A positive pregnancy test was defined by Ͼ50 IU/l plasma β-HCG on day 14 after pre-embryo transfer. An ultrasound scan 3 weeks fertilized and cleaved oocytes, and rate of transferable preafter a positive pregnancy test confirmed a clinical pregnancy.
embryos and mean number of transferred pre-embryos are shown in Table II . The serum concentration of oestradiol on Blood samples and hormone assays S8 was significantly lower in the low LH group compared to Blood samples were taken on stimulation days 1 and 8, and on the the normal LH group (P Ͻ 0.001). A similar proportion of day of oocyte retrieval. The sera were immediately analysed for positive pregnancy tests in the two groups of women is shown oestradiol and aliquots frozen at -20°C for later analyses. Oestradiol in Table III , but those with a low LH concentration on S8 had and LH were measured by time-resolved immunofluorometric a poorer outcome due to a significantly increased risk of early assays; oestradiol by the AutoDELFIA™ oestradiol kit and LH by pregnancy loss (P Ͻ 0.005), and consequently a significantly the AutoDELFIA™ hLH spec. kit (Wallac Oy, Turku, Finland). The decreased chance of delivering a live baby (P Ͻ 0.05). The detection limit of the oestradiol assay was 50 pmol/l, and the intranumber of ectopic pregnancies was higher in the normal than and inter-assay CV 3.9 and 3.8% respectively. The detection limit of in the low LH group, but the difference was not statistically the LH assay given by the manufacturer is 0.05 IU/l, while other significant. studies have shown a detection limit of 0.02 IU/l (Apter et al., 1989) .
The relationship between outcome of IVF and ICSI and
The intra-and inter-assay coefficients of variation (CV) of this assay with varying concentrations of LH were found to be (mean the serum concentration of LH when down-regulation was completed and at the start of ovarian stimulation (stimulation that circulating LH concentrations above a certain critical level are required for optimal oocyte maturation. Thus, the present day 1) is shown in Table IV . None of the differences was study argues against previous studies (Chappel and Howles, statistically significant. 1991; Loumaye et al., 1997) that advocate the insignificance of LH during folliculogenesis. In addition, recent studies in Discussion women with hypogonadotrophic hypogonadism support the This study showed that possible negative consequences of importance of LH for normal follicular development and profound suppression of mid-follicular LH became manifest oocyte maturation. Although follicular development, oocyte only after conception was established. Although the chance of retrieval and pre-embryo development may be obtained using a positive pregnancy test was independent of circulating pure FSH, no pregnancies have so far been reported (Gordon, concentrations of LH, women with low LH concentrations had 1999), whereas a number of pregnancies have been achieved a significantly increased risk of an early termination of the in such women when stimulated with preparations containing pregnancy and consequently a poorer chance of delivery.
both FSH and LH-like activity (Shoham, 1999) . Collectively, the present results suggest that low concentrations
In the present study, all clinical parameters characterizing the stimulation protocol were similar between the low and of LH have a detrimental effect in the outcome of IVF, and normal LH groups, with the important exception of circulating maturation during the follicular phase, which later on is expressed as a reduced ability to form a viable conceptus. concentrations of oestradiol. In accordance with the twocell, two gonadotrophin concept of oestradiol biosynthesis, Previously published clinical and experimental data give some credit to this assumption. Studies in women have shown that significantly reduced concentrations of serum oestradiol were found in the group of women with low LH concentrations a low oestrogen to androgen ratio in the follicular fluid is negatively correlated to a successful outcome of IVF (Yding compared to those with LH concentrations Ͼ0.5 IU/l. Whether such reduced oestradiol concentrations may be linked to an Andersen, 1993) , that oestrogen receptors are identifiable within the human oocyte (Wu et al., 1993) , and that oestrogens underlying mechanism for the observed effects is uncertain, but it may be speculated that in women with low LH concentraapparently exert their actions mostly-if not exclusively-on the oocyte cytoplasm and cellular membrane and not on the tions an intrafollicular environment with reduced oestradiol concentration is created. This oestradiol-depleted intrafollicular nuclear, meiotic maturation (Yoshimura and Wallach, 1987; Tesarik and Mendoza, 1995) . Actual studies on oocytes and environment may be less than optimal for normal oocyte pre-embryos from women with low and normal LH concentrapregnancies in the 2 mg per day group (The Ganirelix dosefinding study group, 1998). tions are needed to evaluate whether the nuclear maturation is insufficient, or whether the intrafollicular cytoplasmic maturaIn the present study, unwanted effects were observed when LH concentrations on stimulation day 8 were below 0.5 IU/l, tion is suboptimal.
The present study demonstrates that nearly half of normowhereas a threshold value of 1.0 or 1.5 IU/l on day 8 or on day 1 of stimulation did not show similar detrimental effects gonadotrophic women subjected to ovarian stimulation with a GnRH analogue combined with recombinant FSH experienced on pregnancy outcome. Therefore, this study suggests that when LH concentrations fall below a limit of around 0.5 IU/l, a profound suppression of circulating concentrations of LH, below 0.5 IU/l, during the mid-follicular phase of ovarian clinical effects become manifest. To make this a suitable threshold value, on the other hand, requires assays which stimulation. Measured on stimulation day 1 (data not shown), this study found that 21% (41/200) of the women had LH monitor LH concentrations in this range with a reasonable accuracy. In this study, two commercial assays were evaluated, concentrations below 0.5 IU/l. This was in contrast to the results of a previous study which showed a much lower and it was found that one assay measured LH concentrations in the 0.5 IU/l range with good precision. Taken together, a frequency of women with low LH concentrations during ovarian stimulation: 6% with LH Ͻ0.5 IU/l on stimulation threshold value of 0.5 IU/l LH on stimulation day 8 seems to reflect possible unwanted effects, which can be measured day 1, and 18% on the day of HCG administration (Loumaye et al., 1997) . The reason for this discrepancy is not clear, but reliably using the presently available assay. Although the present study does not offer an explanation it may be ascribed to differences in the method and efficiency of GnRHa down-regulation, the type of gonadotrophin preparafor the detrimental effects of low LH concentrations, the results clearly raise the question of whether women with tion, or the sensitivity of the LH assays used. Furthermore, the earlier study (Loumaye et al., 1997) consisted of combined low mid-follicular LH concentrations would benefit from supplementation with exogenous LH-like activity during data from three prospective multicentre studies, including a total of 323 women subjected to GnRHa down-regulation and ovarian stimulation. To answer this question however, large prospective clinical trials comparing the use of recombinant stimulation with recombinant or urinary FSH. As pituitary gonadotrophin suppression is less efficient on stimulation day FSH only with preparations containing some LH activity or LH given separately are needed. Such a study including 400 1 than on day 8, it may be expected that LH measurements on day 8 more accurately predict deficiency of endogenous cycles is currently under way in our clinic. LH stimulation. Actually, the data in this study support this view, as LH concentrations below 0.5, 1.0 or 1.5 IU/l on References stimulation day 1 did not predict an increased risk of early
